Daniel Abazia
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Toxicology top 10%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Cannabis and Cannabinoid Research 2
-
- Palliative Care and End-of-Life Issues 1
- Opioid Use Disorder Treatment 1
- Co-authors
- Mary Barna Bridgeman (4 shared papers)Kashelle Lockman (1 shared paper)Kyle P. Edmonds (1 shared paper)Christopher M. Herndon (1 shared paper)Rabia S. Atayee (1 shared paper)Jerry L. Bauman (1 shared paper)Ellen Jones (1 shared paper)C. Lindsay DeVane (1 shared paper)
- Journals
- JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (1 paper)International Journal of Clinical Practice (1 paper)Expert Opinion on Pharmacotherapy (1 paper)Currents in Pharmacy Teaching and Learning (1 paper)American Journal of Hospice and Palliative Medicine® (1 paper)
- Partner nations
- United States
In The Last Decade
Daniel Abazia
6 papers receiving 357 citations
Daniel Abazia's Hit Papers
Peers
Comparison fields: 5 of 75
- Pharmacology 276
- Toxicology 22
- Family Practice 8
- Nephrology 24
- Pediatrics, Perinatology and Child Health 46
Countries citing papers authored by Daniel Abazia
This map shows the geographic impact of Daniel Abazia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Abazia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Abazia more than expected).
Fields of papers citing papers by Daniel Abazia
This network shows the impact of papers produced by Daniel Abazia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Abazia. The network helps show where Daniel Abazia may publish in the future.
Co-authors
The 16 scholars most cited alongside Daniel Abazia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. Hit paper breakdown → | 2017 | 304 |
| 2 | 2017 | 28 | |
| 3 | 2013 | 16 | |
| 4 | 2018 | 15 | |
| 5 | 2018 | 11 | |
| 6 | 2025 | 4 |
About Daniel Abazia
Daniel Abazia is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health, Surgery, Nephrology and Pediatrics, Perinatology and Child Health, having authored 6 papers that have together received 378 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (2 papers), Artificial Intelligence in Healthcare and Education (1 paper), Biomedical and Engineering Education (1 paper), Infant Health and Development (1 paper), Palliative Care and End-of-Life Issues (1 paper), Opioid Use Disorder Treatment (1 paper), Case Reports on Hematomas (1 paper) and Eosinophilic Disorders and Syndromes (1 paper). The work is most often cited by research in Pharmacology (276 citations), Toxicology (22 citations), Family Practice (8 citations), Nephrology (24 citations) and Pediatrics, Perinatology and Child Health (46 citations). Daniel Abazia has collaborated with scholars based in United States. Frequent co-authors include Mary Barna Bridgeman, Kashelle Lockman, Kyle P. Edmonds, Christopher M. Herndon, Rabia S. Atayee, Jerry L. Bauman, Ellen Jones, C. Lindsay DeVane, Donald C. Moore and Nicholas R. Nelson. Their work appears in journals such as JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, International Journal of Clinical Practice, Expert Opinion on Pharmacotherapy, Currents in Pharmacy Teaching and Learning and American Journal of Hospice and Palliative Medicine®.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.